Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7456 USD | -6.18% | -34.60% | -46.74% |
Jun. 11 | Nestle's Health Unit to Take Full Control of Microbiota-Based Therapeutic | CI |
Jun. 07 | Canaccord Genuity Adjusts Price Target on Seres Therapeutics to $10 From $15, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.74% | 113M | |
+16.93% | 123B | |
+17.01% | 111B | |
-7.23% | 23.63B | |
+1.98% | 22.58B | |
-14.29% | 17.26B | |
-6.79% | 17.6B | |
-37.63% | 17.61B | |
+2.17% | 13.55B | |
+24.42% | 11.34B |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- Transcript : Seres Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 09